Circulating Tumor DNA Predicts Recurrence After Liver Metastasis Resection

◇ RESEARCH

A systematic review and meta-analysis found that circulating tumor DNA (ctDNA) serves as a biomarker for recurrence after curative resection of colorectal cancer liver metastases, potentially guiding post-surgical surveillance strategies. (Clinical Colorectal Cancer)